banner

Experts at EFNS 2012 Symposium believe earlier initiation of continuous dopaminergic stimulation (CDS) therapy is beneficial in advanced Parkinson's disease (PD)
05 Oct 2012
Experts at EFNS 2012 symposium believe earlier initiation of continuous dopaminergic stimulation (CDS) therapy is beneficial in advanced Parkinson's disease (PD).
Read more

Webinar with EURO-INF Project Leader Professor K Ray Chaudhuri discloses significant benefits of apomorphine and intrajejunal levodopa infusion in advanced Parkinson's disease.
25 Jun 2012
Webinar with EURO-INF Project Leader Professor K Ray Chaudhuri discloses significant benefits of apomorphine and intrajejunal levodopa infusion in advanced Parkinson's disease.
Read more

APO-go®: simplifying the challenge of Parkinson’s therapy in advanced disease.
11 May 2012
“Advanced Parkinson’s disease poses one of the biggest challenges in clinical practice. Patients can be affected with a huge range of motor and non-motor symptoms,” according to Professor K Ray Chaudhuri (King’s College Hospital, London and Clinical Director of the National Parkinson Foundation), co-chair of a symposium on the challenges in treating of the advanced states of Parkinson’s disease held at the MDPD Congress in Berlin last week.
Read more

Announcement regarding Marketing Authorization Approval in Japan of Apokyn® Subcutaneous Injection 30 mg (Apomorphine Hydrochloride Hydrate) for Treatment of Parkinson's Disease
02 Apr 2012
Our Japanese Partner, Kyowa Hakko Kirin Co,. Ltd, received confirmation of their Marketing Authorisation for apomorphine injection in Japan on 30th March 2012.
Read more